SEO URLwww.firestrike.ai/deals/novavax-pfizer-acquisition-2026
acquisitionAnnounced · Jan 21, 2026BiotechnologySource · Unverified ReportsArticle · Factual
Pfizer acquires Novavax
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
Novavax
NASDAQ: NVAX · Gaithersburg, Maryland
Acquirer
Pfizer
Financial Stake
Status
Announced
Pfizer agreed to acquire Novavax. Reported deal value: Undisclosed. Status: Announced. Sector: Biotechnology. Target headquarters context: Gaithersburg, Maryland, United States.
This page summarizes publicly available information about the transaction as of 2026-01-21. Figures and status may change as filings and press coverage update.
Novavax Inc. stocks have been trading up by 14.27 percent fueled by promising vaccine trial results boosting investor confidence
Deal timeline
Announced
Jan 21, 2026 · stockstotrade.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology. Figures and status may change as sources update.
Sources: stockstotrade.com · Primary article · FireStrike proprietary index